Pharmacogenetics : Diabetes

Welcome to Diabetes Meet 2020 on may 13-14,Singapore. Genomic studies have greatly advanced our understanding of the multifactorial aetiology of diabetes especially in type 2diabetes (Diabetes Mellitus) as well as the multiple subtypes of monogenic diabetes mellitus. These studies focus on a few feasible candidate genes involved in drug pharmacodynamics / pharmacokinetics, or those associated with Type 2 diabetes as a disease phenotype.Here in relation to diabetes the main focus is on mostly used drugs in diabetes treatment such as sulfonylureas, metformin and thiazolidinediones (troglitazone, pioglitazone, and rosiglitazone).

• Genomics
• Chemogenomics
• Clinomics
• Genetic engineering
• Toxicogenomics
• Metabolomics
• Pharmacovigilance
• Population groups in biomedicine
• Toxgnostics
• Medical terminology

                                           

                                            To know more please visit this website:                                      https://diabetesmeetings.alliedacademies.com/

                                           We look forward for a positive response.

                                                          With best Regards,

                                             Emili Sherlyn | Program Manager
                                               Phone: + 442039365603-5081
                                               Whatsapp: 44-20-3318-7472